Next Article in Journal
Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
Next Article in Special Issue
Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Previous Article in Journal
The Willingness of the Healthcare Professionals Working in Healthcare Institutions to Accept the First Dose of COVID-19 Vaccine in Jordan: A National Survey
Previous Article in Special Issue
A Comparative Analysis of a Self-Reported Adverse Events Analysis after Receiving One of the Available SARS-CoV-2 Vaccine Schemes in Ecuador
 
 
Article

Article Versions Notes

Vaccines 2022, 10(7), 1139; https://doi.org/10.3390/vaccines10071139
Action Date Notes Link
article xml file uploaded 17 July 2022 11:54 CEST Original file -
article xml uploaded. 17 July 2022 11:54 CEST Update -
article pdf uploaded. 17 July 2022 11:54 CEST Version of Record https://www.mdpi.com/2076-393X/10/7/1139/pdf-vor
article supplementary file uploaded. 17 July 2022 11:54 CEST - https://www.mdpi.com/2076-393X/10/7/1139#supplementary
article html file updated 17 July 2022 12:13 CEST Original file -
article html file updated 18 July 2022 05:12 CEST Update -
article xml file uploaded 20 July 2022 08:13 CEST Update -
article xml uploaded. 20 July 2022 08:13 CEST Update https://www.mdpi.com/2076-393X/10/7/1139/xml
article pdf uploaded. 20 July 2022 08:13 CEST Updated version of record https://www.mdpi.com/2076-393X/10/7/1139/pdf
article html file updated 20 July 2022 08:15 CEST Update -
article html file updated 13 August 2022 02:11 CEST Update https://www.mdpi.com/2076-393X/10/7/1139/html
Back to TopTop